Neuroone Medical Technologies is trading 8.3% up today at $1.79 following encouraging clinical feedback from a Mayo Clinic epilepsy study regarding its OneRF Ablation System.
- Positive physician responses and seizure reduction data are driving renewed investor interest in the stock.
- The company's performance stands out as a significant gainer despite broader weakness across the healthcare sector today.